Assessment of the Relationship between Metabolic Activity of Uveal Melanoma in Positron Emission Tomography (PET) and Chromosome 3 Monosomy
Czech and Slovak Ophthalmology · 2026
DOI: 10.31348/2026/31 ↗Kurz gefasst
Fachartikel in der Zeitschrift Czech and Slovak Ophthalmology, 2026. Verfasst von Kristýna Mrázová und 5 weiteren Autor:innen. Hauptthemen laut MEDLINE: Melanoma, Uveal Neoplasms, Chromosomes, Human, Pair 3, Monosomy.
Abstract (Originalsprache)
Introduction
Uveal melanoma is the most common primary malignant intraocular tumor in adults. A major prognostic factor is the cytogenetic profile of the tumor, particularly the presence of monosomy of chromosome 3, which is associated with an increased risk of developing distant metastases. The aim of this study was to determine whether there is a relationship between the metabolic activity of the tumor assessed by SUVmax (maximum standardized uptake value) in PET/CT or PET/MRI and the presence of monosomy 3 in the tumor cytogenetic profile. Material and Methods: A total of 37 patients with uveal melanoma were included in this retrospective analysis. All patients underwent staging whole-body PET/CT or PET/MRI with calculation of SUVmax, followed by enucleation of the affected eye and cytogenetic examination of the tumor. All patients were examined and subsequently treated between 2009 and 2024 at the Department of Ophthalmology, University Hospital Plzeň.
Results
Monosomy 3 was detected in 21 patients. In this group, SUVmax values ranged from 2.7 to 14.5 (mean 6.6; median 6.5). Metastatic dissemination occurred within 5 years of diagnosis in 16 patients (76.2%), and in an additional four patients after a longer interval. Disomy 3 was present in 16 patients, with SUVmax values ranging from 1.1 to 8.0 (mean 3.4; median 3.4). Metastatic spread occurred in only one patient (6.3%). The difference in SUVmax values between the groups was highly statistically significant (p = 0.00012).
Conclusion
Higher SUVmax values were associated with the presence of monosomy 3 and an increased risk of metastatic progression. PET/CT and PET/MRI imaging may be beneficial not only for diagnosis and primary staging of metastatic disease, but also for indirect estimation of the tumor’s genetic variant.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Zitieren
APA
Mrázová, K., Hecová, L., Rusňák, Š., Ferda, J., Ferdová, E., & Vaneček, T. (2026). Assessment of the Relationship between Metabolic Activity of Uveal Melanoma in Positron Emission Tomography (PET) and Chromosome 3 Monosomy. Czech and Slovak Ophthalmology. https://doi.org/10.31348/2026/31
Vancouver
Mrázová K, Hecová L, Rusňák Š, Ferda J, Ferdová E, Vaneček T. Assessment of the Relationship between Metabolic Activity of Uveal Melanoma in Positron Emission Tomography (PET) and Chromosome 3 Monosomy. Czech and Slovak Ophthalmology. 2026. doi:10.31348/2026/31
BibTeX
@article{Mrzov2026,
author = {Mrázová, Kristýna and Hecová, Lenka and Rusňák, Štěpán and Ferda, Jiří and Ferdová, Eva and Vaneček, Tomáš},
title = {Assessment of the Relationship between Metabolic Activity of Uveal Melanoma in Positron Emission Tomography (PET) and Chromosome 3 Monosomy},
journal = {Czech and Slovak Ophthalmology},
year = {2026},
doi = {10.31348/2026/31}
}
EUVIMED